Onc.AI: Onc.AI receives US FDA's breakthrough device designation for its serial CT response score deep learning model

Onc.AI, a digital health company developing AI─driven oncology clinical management solutions using deep learning imaging AI, announced that the US Food and Drug Administration (FDA) has awarded Breakthrough Device